Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.
Open accessThe DOI matches its Crossref record.
Abstract
In this study we define the proliferative compartments of in vivo human epidermis, using specific antibodies related to cell differentiation (beta 1 and beta 4 integrins and K1/K10 differentiation keratins) and cell cycle (proliferating cell nuclear antigen [PCNA]) in combination with flow cytometric quantitation of the DNA content and optical characteristics of the cells. The beta 1 integrin (CD29) marked both of the potentially proliferative subsets in normal epidermis. One subset of normal epidermis is CD29+ K1/K10-, which was predominantly basal, and found to be comprised of slow cycling, small cells with primitive cytoplasmic organization. The vast majority (95.5%) of these cells were in a quiescent state (G0/early G1) as indicated by their lack of the cyclin, PCNA. The other proliferative subset of normal epidermis was CD29+ K1/K10+, which was suprabasal and occasional basal, highly proliferative, larger in size, and which exhibited a more complex cytoplasmic structure. Because early differentiation (K1/K10 expression) has begun in the CD29+ K1/K10+ subset, it is highly likely that they represent the proliferative population which is capable of transiently amplifying itself before terminal differentiation. Within lesional psoriatic epidermis, similar proliferative cell populations were present as in normal epidermis, and the hyperproliferative defect was localized to the beta 1 and beta 4 integrin+, K1/K10- populations, which in normal epidermis is basally located and quiescent with regard to cell cycle. In psoriatic epidermis, a six- to sevenfold increase in the number of cells in the S/G2+M phase of cell cycle was found among CD29+ K1/K10- cells (p < 0.05). Furthermore, all lesional K1/K10- cells showed high PCNA positivity, indicating that all these cells had been recently induced into cell cycle. By contrast, the proportion of cycling cells among lesional psoriatic CD29+ K1/K10+ keratinocytes was similar to normals. Anti-HLA-DR, CD45, and vimentin antibodies were used to concomitantly track the proliferative states of Langerhans cell, melanocyte, and infiltrating leukocyte populations. In normal epidermis, the cycling fractions (cells in S/G2/M phase) of these cells were similar to the CD29+K1/K10- keratinocytes, whereas in lesional epidermis their cycling pools were increased relative to normal, but not so much as the proliferative fractions of psoriatic CD29+ K1/K10- keratinocytes. These data demonstrate the use of simultaneous analysis of integrin expression, differentiation keratins, cyclin, cell cycle status, and optical characteristics of freshly isolated human epidermal cells. Such analysis allowed the physical identification and quantification of cy cling populations in normal human skin, and has enabled the precise location of the primary epidermal proliferative defect in psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Baliwag, J., Barnes, D. H., & Johnston, A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.014 · Cited by 373
Immunopathogenesis of psoriasis
Sabat, R., Philipp, S., Höflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H., Sterry, W., & Wolk, K. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00629.x · Cited by 373
The pathogenesis of psoriasis: immunological facts and speculations
Bos, J. D., & De Rie, M. A. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01381-4 · Cited by 284
Detection of Telomerase Activity in Malignant and Nonmalignant Skin Conditions
Stan Taylor, R., Ramirez, R. D., Ogoshi, M., Chaffins, M., Piatyszek, M. A., & Shay, J. W. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12345811 · Cited by 267
Gudjonsson, J. E., Johnston, A., Dyson, M., Valdimarsson, H., & Elder, J. T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700807 · Cited by 266
Brain-Skin Connection: Stress, Inflammation and Skin Aging
Chen, Y., & Lyga, J. (2014) · Inflammation & Allergy-Drug Targets · doi:10.2174/1871528113666140522104422 · Cited by 263
Lippens, S., Kockx, M., Knaapen, M., Mortier, L., Polakowska, R., Verheyen, A., Garmyn, M., Zwijsen, A., Formstecher, P., Huylebroeck, D., et al. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400785 · Cited by 245
“Psoriasis is characterized by keratinocyte hyperproliferation, loss of granular layer and parakeratotic differentiation.(32,33) So far, this epidermal hyperproliferation has not been explained on a molecular basis and it is still unclear whether the major defect resides within the keratinocyte, the immune compartment…”
BackgroundBata-Csorgo, Z., Hammerberg, C., Voorhees, J. J., & Cooper, K. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117659 · Cited by 225
Self-citationNickoloff, B. J. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.280201.x · Cited by 78
Ethanol and acetone stimulate the proliferation of HaCaT keratinocytes
Farkas, �., Kem�ny, L., Sz�ll, M., Dobozy, A., & Bata-Cs�rgo, Z. (2003) · Archives of Dermatological Research · doi:10.1007/s00403-003-0399-2 · Cited by 69
“The epidermal hyperplasia in psoriasis is characterized by an increased percentage of normally quiescent basal keratinocytes in the proliferative phases of the cell cycle ( Bata-Csorgo et al. 1993 ).”
BackgroundMyeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice
Neu, S. D., Strzepa, A., Martin, D., Sorci-Thomas, M. G., Pritchard, K. A., & Dittel, B. N. (2021) · Antioxidants · doi:10.3390/antiox10091338 · Cited by 40
Metadata
- Authors
- Bata-Csorgo, Z., Hammerberg, C., Voorhees, J. J., & Cooper, K. D.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-10-01
- Volume
- 178
- Issue
- 4
- Pages
- 1271-1281
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2109264320
- Cited by
- 127
- References
- 0
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.